Medartis Holding AG / Key word(s): Personnel PRESS RELEASE Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement. Medartis announces that its CEO, Christoph Brönnimann, has decided to resign from his position and leave the company to pursue other opportunities. Christoph will continue to lead Medartis until a successor is onboarded. He will remain focused on the execution of the company’s strategy and committed to a smooth transition to the new leadership. The Board has initiated a search for his successor and will announce an appointment in due course. Medartis Chairman, Marco Gadola, said: “Under Christoph’s leadership, Medartis has significantly accelerated its growth in its key markets, broadened the product portfolio and strengthened its standing with leading surgeons and hospitals worldwide. He has also expanded the capabilities of the organization and fostered an engaging culture, positioning the company for future success. This work will continue and growth remains our top priority.”
Christoph added: “While this has been a difficult decision for me, I am proud of what we have accomplished together over the past five years. I will leave behind a talented executive team, a passionate organization and a company with huge potential for future growth.”
The Board of Directors wholeheartedly thanks Christoph for his leadership, valuable contributions to Medartis and its success during his tenure, and wishes him all the best for his future endeavors. About Medartis Contact: Medartis Holding AG Corporate Communications End of Inside Information |
Language: | English |
Company: | Medartis Holding AG |
Hochbergerstrasse 60E | |
4057 Basel | |
Switzerland | |
Phone: | +41 61 633 34 34 |
Fax: | +41 61 633 34 00 |
E-mail: | info@medartis.com |
Internet: | www.medartis.com |
ISIN: | CH0386200239 |
Valor: | 38620023 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1921997 |
End of Announcement | EQS News Service |
|
1921997 11-Jun-2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.